Former Arizona senator joins Covington

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Former Arizona senator joins Covington

kyl-thumbnail-45.jpg

Jon Kyl, who recently left Congress as the second-highest ranking Republican in the US Senate, is joining Covington & Burling’s global public policy and government affairs group in Washington DC

kyl20thumbnail.jpg

Kyl, who was most recently the Senate minority whip, was named as one of the 100 most influential people in the world by Time magazine in 2010. 

He will advise Covington clients on the policy aspects of tax, health care, defence, national security and IP matters.

Though he admitted the bills were "not perfect", Kyl supported SOPA and PIPA last year, saying that “legislation should be enacted to prevent foreign websites whose primary business is trafficking in infringed goods from doing business with Americans”.

Kyl also sponsored the Patent Reform Act of 2008.

more from across site and SHARED ros bottom lb

More from across our site

Via's Qi pool expands its footprint in Asia with the addition of Chinese smartphone giant and Japanese auto company
Matthew Cassie becomes the tenth partner to join the firm’s London outpost, and the second since it opened its new headquarters in May this year
A&O Shearman and Fish & Richardson invested in German talent, meanwhile, major firms have assembled for an on the merits case pitting KeeeX against OpenAI and Adobe
Julia Bishop is director of IP at Twilio in the US
Hellberg is an IP director at Essity in Sweden
Teemu Itälä is head of legal and compliance for technology standards at Nokia in Finland
Palińska is the business & IP law lead at CD Projekt Red in Poland
Schwitulla is the head of litigation management at Nokia in Germany
David Degen is senior IP counsel at Novartis, Switzerland
Demetrio Roberto Cavicchia is an IP director at Angelini Pharma in Italy
Gift this article